Vulvovaginal candidiasis (VVC)
Clinical trials for Vulvovaginal candidiasis (VVC) explained in plain language.
Never miss a new study
Get alerted when new Vulvovaginal candidiasis (VVC) trials appear
Sign up with your email to follow new studies for Vulvovaginal candidiasis (VVC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Boric acid inserts aim to cure yeast infections in new trial
Disease control OngoingThis study tests whether boric acid vaginal inserts (600 mg) taken for 7 or 14 days can safely and effectively treat yeast infections. About 400 women aged 12 and older with active symptoms will participate. The goal is to see if all signs and symptoms disappear without needing m…
Matched conditions: VULVOVAGINAL CANDIDIASIS (VVC)
Phase 3 • Sponsor: pH-D Feminine Health LLC • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New thrush treatment shows promise in early trial
Symptom relief OngoingThis study tests a product called pHyph for treating thrush (a vaginal yeast infection) in adult women. The goal is to see if pHyph reduces symptoms like itching, burning, and irritation. 48 women will either use pHyph daily for 6 days or receive no treatment, and researchers wil…
Matched conditions: VULVOVAGINAL CANDIDIASIS (VVC)
Sponsor: Gedea Biotech AB • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC